Wutah dodolan YoY sajrone rolas wulan kepungkur: Lumos Therapeutics (LUMO)

Logo grafis Lumos Pharma, Inc. (LUMO)

Lumos Pharma, Inc. (LUMO) is integrating ESG standards and bioethics into the development of drugs for rare pathologies. Year-over-year revenue dynamics over the last 12 months illustrate the financial trend, where 41.70 indicates the level of this metric. Intense competition for patents in the metabolic sector creates risks, while the R&D stage for growth hormone limits scaling due to a lack of current sales.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Lumos Pharma Corp (LUMO) kanggo 11.02.2024 - 20.02.2024

Ringkesan rincian data analitis Lumos Pharma (LUMO)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:LUMO (Lumos Therapeutics)
Produk seri lumos-pharma.com

As a portfolio manager, I utilize this indicator to verify cash flow resilience under stress conditions. The year-over-year product sales volume dynamics for the TTM measure the percentage change in revenue over a rolling year, which allows for the identification of revenue stagnation at Lumos Pharma, Inc. (LUMO) amid a critical deficit of commercial receipts and high R&D expenditure pressure.

Pesaing Lumos Pharma, Inc. (LUMO)

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BIOA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Fractyl - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|VTVT (vTv Therapeutics Inc) - Wutah dodolan YoY (TTM)|Agape ATP - Wutah dodolan taun lumaku|Wutah pendapatan YoY sajrone 12 wulan kepungkur PLUR (Pluri Inc)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Synlogic Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Wutah pendapatan taun lumaku|Spruce Biosciences Inc. - Wutah dodolan YoY (TTM)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)